- Home
- HSLV vs ORIC Comparison
HSLV vs ORIC Comparison
Compare HSLV & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
HOLD
Current Price
$12.05
Company Overview
Basic Information| Metric | HSLV | ORIC |
|---|---|---|
| Founded | N/A | 2014 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.2B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | HSLV | ORIC |
|---|---|---|
| Price | $6.10 | $12.05 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 13 |
| Target Price | N/A | ★ $20.00 |
| AVG Volume (30 Days) | 195.6K | ★ 1.4M |
| Earning Date | N/A | 05-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 19.67 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.80 | $3.90 |
| 52 Week High | $6.52 | $14.93 |
Technical Indicators
Market Signals| Indicator | HSLV | ORIC |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 49.72 |
| Support Level | N/A | $11.37 |
| Resistance Level | N/A | $12.12 |
| Average True Range (ATR) | 0.00 | 0.84 |
| MACD | 0.00 | -0.21 |
| Stochastic Oscillator | 0.00 | 36.05 |
Price Performance
Historical Comparison HSLV
ORIC
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.